{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:18:41Z","timestamp":1793319521666,"version":"4.5.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>To verify prognostic significance of the 2004 World Health Organization (WHO)\/International Society of Urological Pathology (ISUP) grading systems, we retrospectively studied the tumors of 1,515 patients who underwent transurethral resection of primary non\u2013muscle-invasive urothelial tumors (pTa, 1,006 patients; pT1, 509 patients) confined to the bladder. Cases were classified according to the 2004 WHO\/ISUP systems as 212 cases of papillary urothelial neoplasm of low malignant potential (PUNLMP), 706 low-grade papillary urothelial carcinomas (LPUCs), and 597 high-grade papillary urothelial carcinomas (HPUCs). PUNLMP showed the statistically significantly lowest recurrence cumulative incidence compared with the other tumor types. There were significant differences and trends for higher progression and cancer-specific mortality cumulative incidence in the following order: PUNLMP, LPUC, pTa HPUC, and pT1 HPUC. No differences of progression and cancer-specific mortality cumulative incidence were found between pTa and pT1 LPUC. Our study validates the usefulness of the 2004 WHO\/ISUP system to classify urothelial tumors into prognostically distinct categories that would contribute to the design of therapeutic and monitoring strategies for patients with non\u2013muscle-invasive bladder urothelial tumors.<\/jats:p>","DOI":"10.1309\/ajcp12mrvvhtckej","type":"journal-article","created":{"date-parts":[[2010,4,15]],"date-time":"2010-04-15T18:30:42Z","timestamp":1271356242000},"page":"788-795","source":"Crossref","is-referenced-by-count":120,"title":["Prognostic Significance of the 2004 WHO\/ISUP Classification for Prediction of Recurrence, Progression, and Cancer-Specific Mortality of Non\u2013Muscle-Invasive Urothelial Tumors of the Urinary Bladder"],"prefix":"10.1093","volume":"133","author":[{"given":"Chin-Chen","family":"Pan","sequence":"first","affiliation":[{"name":"1Department of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"3National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hwa","family":"Chang","sequence":"additional","affiliation":[{"name":"2Division of Urology, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Kuo","family":"Chen","sequence":"additional","affiliation":[{"name":"2Division of Urology, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Jung","family":"Yu","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"3National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hao","family":"Sun","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"3National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M. T.","family":"Ho","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"3National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,5,1]]},"reference":[{"key":"2023011906591756200_b1-1330788","volume-title":"Histological Typing of Urinary Bladder Tumours","author":"Mostofi","year":"1973"},{"key":"2023011906591756200_b2-1330788","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"2023011906591756200_b3-1330788","volume-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs","author":"Eble","year":"2004"},{"key":"2023011906591756200_b4-1330788","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/modpathol.3880300","article-title":"Comparison of the WHO\/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors","volume":"14","author":"Alsheikh","year":"2001","journal-title":"Mod Pathol"},{"key":"2023011906591756200_b5-1330788","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1309\/94B6-8VFB-MN9J-1NF5","article-title":"Grading and staging of bladder carcinoma in transurethral resection specimens: correlation with 105 matched cystectomy specimens","volume":"113","author":"Cheng","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"2023011906591756200_b6-1330788","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/modpathol.3880241","article-title":"Relationship of cytokeratin 20 and CD44 protein expression with WHO\/ISUP grade in pTa and pT1 papillary urothelial neoplasia","volume":"13","author":"Desai","year":"2000","journal-title":"Mod Pathol"},{"key":"2023011906591756200_b7-1330788","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.urology.2005.03.011","article-title":"Urothelial carcinoma of the upper urinary tract: comparison between the WHO\/ISUP 1998 consensus classification and WHO 1999 classification system","volume":"66","author":"Holm\u00e4ng","year":"2005","journal-title":"Urology"},{"key":"2023011906591756200_b8-1330788","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/jcp.55.12.900","article-title":"Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO\/ISUP classification system and comparison with conventional grading systems","volume":"55","author":"Oosterhuis","year":"2002","journal-title":"J Clin Pathol"},{"key":"2023011906591756200_b9-1330788","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/00000478-200112000-00009","article-title":"Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder","volume":"25","author":"Pich","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"2023011906591756200_b10-1330788","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0090-4295(02)01705-3","article-title":"Comparison of WHO\/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression","volume":"60","author":"Samaratunga","year":"2002","journal-title":"Urology"},{"key":"2023011906591756200_b11-1330788","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.juro.2007.05.126","article-title":"Survival following the diagnosis of noninvasive bladder cancer: WHO\/International Society of Urological Pathology versus WHO classification systems","volume":"178","author":"Schned","year":"2007","journal-title":"J Urol"},{"key":"2023011906591756200_b12-1330788","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1309\/0KATYHQBJD5XHQ8J","article-title":"Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO\/ISUP system by immunophenotyping and follow-up","volume":"121","author":"Yin","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"2023011906591756200_b13-1330788","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"2023011906591756200_b14-1330788","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1158\/1078-0432.CCR-06-1210","article-title":"Cumulative incidence in competing risks data and competing risks regression analysis","volume":"13","author":"Kim","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2023011906591756200_b15-1330788","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1464-410x.1998.00628.x","article-title":"The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index","volume":"81","author":"Allard","year":"1998","journal-title":"Br J Urol"},{"key":"2023011906591756200_b16-1330788","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000112600","article-title":"Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year","volume":"80","author":"Guney","year":"2008","journal-title":"Urol Int"},{"key":"2023011906591756200_b17-1330788","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00005392-199909010-00019","article-title":"Recurrence and progression in low grade papillary urothelial tumors","volume":"162","author":"Holmang","year":"1999","journal-title":"J Urol"},{"key":"2023011906591756200_b18-1330788","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0022-5347(05)65168-3","article-title":"Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression","volume":"167","author":"Holmang","year":"2002","journal-title":"J Urol"},{"key":"2023011906591756200_b19-1330788","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/S0022-5347(05)68075-5","article-title":"Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder","volume":"162","author":"Leblanc","year":"1999","journal-title":"J Urol"},{"key":"2023011906591756200_b20-1330788","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0022-5347(05)64553-3","article-title":"Interobserver discrepancy using the 1998 World Health Organization\/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care","volume":"168","author":"Murphy","year":"2002","journal-title":"J Urol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/133\/5\/788\/48763795\/ajcp_133_5_788.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/133\/5\/788\/48763795\/ajcp_133_5_788.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T07:00:43Z","timestamp":1674111643000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/133\/5\/788\/1761136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,1]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2010,5,1]]},"published-print":{"date-parts":[[2010,5,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcp12mrvvhtckej","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,5,1]]},"published":{"date-parts":[[2010,5,1]]}}}